Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF.

Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. Eur J Heart Fail. 2020 11; 22(11):2093-2101.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Aminobutyrates
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biphenyl Compounds
Drug Combinations
Female
Heart Failure
Humans
Male
Prospective Studies
Randomized Controlled Trials as Topic
Stroke Volume
Treatment Outcome
Uric Acid
Valsartan

authors with profiles

Michael R. Zile